====== AICAR 240μM R03 exp116 ======
==== Mechanism of Action ====
Metabolic intermediate in purine biosynthesis, activates AMPK, has other putative targets
* **Class / Subclass 1:** Metabolism / Metabolite
* **Class / Subclass 2:** Signal Transduction / Kinase Activator
==== Technical Notes ====
* **PubChem Name:** %%Acadesine%%
* **Synonyms:** Acadesine; AICA Riboside
* **CAS #:** 2627-69-2
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/17513|17513]]
* **IUPAC:** %%5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazole-4-carboxamide%%
* **INCHI Name:** InChI=1S/C9H14N4O5/c10-7-4(8(11)17)12-2-13(7)9-6(16)5(15)3(1-14)18-9/h2-3,5-6,9,14-16H,1,10H2,(H2,11,17)/t3-,5-,6-,9-/m1/s1
* **INCHI Key:** RTRQQBHATOEIAF-UUOKFMHZSA-N
* **Molecular Weight:** 258.23
* **Canonical SMILES:** C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N
* **Isomeric SMILES:** C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N
* **Molecular Formula:** C9H14N4O5
{{:chemogenomics:structures:chem-0072.svg?nolink}}
* **Supplier Name:** AK scientific
* **Catalog #:** AMTNS043
* **Lot #:** DM-079-143-2
* **LCMS:** Tr 0.15 min, m/z 259+ [M+H]+, 257- [M-H]-
* **Platform ID:** AICAR
* **Min:** -11.2747; **Max:** 24.1473
{{:chemogenomics:dose_response:dr_68.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |N/A |
| IC30 |N/A |
| IC40 |N/A |
| IC50 |N/A |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 03
* **Dose**: 240µM
* **Days of incubation**: 8
* **Doublings**: 1.9
* **Numbers of reads**: 10607864
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|4/108|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/AICAR_240uM_Round-3_exp116.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp116.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:U:UCK2|UCK2]]|-4.05|<0.01|
|[[:human_genes:H:HCFC1|HCFC1]]|-3.67|0.17|
|[[:human_genes:N:NT5C2|NT5C2]]|-2.90|0.02|
|[[:human_genes:F:FAM122A|FAM122A]]|-2.68|0.04|
|[[:human_genes:N:NRAS|NRAS]]|-2.65|0.04|
|[[:human_genes:C:C7orf60|C7orf60]]|-2.55|0.11|
|[[:human_genes:C:CLK3|CLK3]]|-2.53|0.07|
|[[:human_genes:G:GNA13|GNA13]]|-2.48|0.07|
|[[:human_genes:T:TCF4|TCF4]]|-2.41|0.17|
|[[:human_genes:P:PROSER1|PROSER1]]|-2.39|0.16|
|[[:human_genes:A:ACIN1|ACIN1]]|-2.37|0.16|
|[[:human_genes:I:IRF4|IRF4]]|-2.35|0.16|
|[[:human_genes:N:NKAP|NKAP]]|-2.33|0.20|
|[[:human_genes:I:ING3|ING3]]|-2.32|0.14|
|[[:human_genes:M:MCM5|MCM5]]|-2.32|0.47|
|[[:human_genes:P:PLD2|PLD2]]|-2.32|0.17|
|[[:human_genes:K:KPNB1|KPNB1]]|-2.31|0.59|
|[[:human_genes:D:DRC1|DRC1]]|-2.30|0.14|
|[[:human_genes:C:CTC1|CTC1]]|-2.27|0.17|
|[[:human_genes:B:BTK|BTK]]|-2.26|0.16|
|[[:human_genes:T:TTC27|TTC27]]|-2.25|0.26|
|[[:human_genes:D:DCLRE1B|DCLRE1B]]|-2.21|0.16|
|[[:human_genes:S:SMG7|SMG7]]|-2.21|0.36|
|[[:human_genes:C:C9orf41|C9orf41]]|-2.20|0.27|
|[[:human_genes:I:IP6K1|IP6K1]]|-2.16|0.17|
|[[:human_genes:E:ERG|ERG]]|-2.14|0.23|
|[[:human_genes:A:ACSM1|ACSM1]]|-2.14|0.17|
|[[:human_genes:B:BICD1|BICD1]]|-2.12|0.17|
|[[:human_genes:B:BCL2|BCL2]]|-2.12|0.17|
|[[:human_genes:K:KEAP1|KEAP1]]|-2.09|0.18|
|[[:human_genes:G:GLRX5|GLRX5]]|3.65|<0.01|
|[[:human_genes:P:PIK3CD|PIK3CD]]|3.83|<0.01|
|[[:human_genes:S:SLC19A1|SLC19A1]]|3.85|<0.01|
|[[:human_genes:F:FAF2|FAF2]]|3.86|<0.01|
|[[:human_genes:T:TP53|TP53]]|3.96|<0.01|
|[[:human_genes:R:RICTOR|RICTOR]]|3.99|<0.01|
|[[:human_genes:C:CD19|CD19]]|4.04|<0.01|
|[[:human_genes:H:HEATR3|HEATR3]]|4.05|<0.01|
|[[:human_genes:B:BCL2L11|BCL2L11]]|4.13|<0.01|
|[[:human_genes:S:SLC25A51|SLC25A51]]|4.19|<0.01|
|[[:human_genes:N:NFU1|NFU1]]|4.23|<0.01|
|[[:human_genes:U:UBE2H|UBE2H]]|4.42|<0.01|
|[[:human_genes:M:MARCH5|MARCH5]]|4.71|<0.01|
|[[:human_genes:M:MTHFD1L|MTHFD1L]]|4.73|<0.01|
|[[:human_genes:M:MAPKAP1|MAPKAP1]]|4.89|<0.01|
|[[:human_genes:S:SHMT2|SHMT2]]|5.14|<0.01|
|[[:human_genes:S:SLC25A32|SLC25A32]]|5.30|<0.01|
|[[:human_genes:V:VDAC2|VDAC2]]|5.37|<0.01|
|[[:human_genes:M:MTHFD2|MTHFD2]]|5.41|<0.01|
|[[:human_genes:Y:YPEL5|YPEL5]]|5.57|<0.01|
|[[:human_genes:M:MTRR|MTRR]]|5.85|<0.01|
|[[:human_genes:I:IMPDH2|IMPDH2]]|5.89|<0.01|
|[[:human_genes:Y:YLPM1|YLPM1]]|6.11|<0.01|
|[[:human_genes:B:BAK1|BAK1]]|6.13|<0.01|
|[[:human_genes:M:MMACHC|MMACHC]]|6.57|<0.01|
|[[:human_genes:A:ADSS|ADSS]]|7.31|<0.01|
|[[:human_genes:M:MTR|MTR]]|7.47|<0.01|
|[[:human_genes:A:AK2|AK2]]|8.26|<0.01|
|[[:human_genes:N:NUDT2|NUDT2]]|8.48|<0.01|
|[[:human_genes:A:ADK|ADK]]|8.50|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp211|AICAR 240μM R05 exp211]]|0.209||
|[[:results:exp134|MS023 2μM R03 exp134]]|0.154||
|[[:results:exp135|MS023 7μM R03 exp135]]|0.129||
|[[:results:exp485|GSK626616 14μM R08 exp485]]|0.118||
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|0.113||
|[[:results:exp456|Benzoate 20000μM R08 exp456]]|0.104||
|[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|0.102||
|[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|0.099||
|[[:results:exp234|Ethanol 0.01 R05 exp234]]|0.093||
|[[:results:exp512|Olaparib 4μM R08 exp512]]|0.091||
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|0.09||
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|0.087||
|[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|0.084||
|[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.083||
|[[:results:exp85|UM0129480 7μM R02 exp85]]|0.078||
|[[:results:exp443|SNS-032 15μM R08 exp443]]|0.075||
|[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|0.074||
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|0.073||
|[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|0.073||
|[[:results:exp80|RO-3307 4.7μM R02 exp80]]|0.072||
|[[:results:exp492|iCRT14 30μM R08 exp492]]|0.069||
|[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|0.069||
|[[:results:exp505|ML-792 0.2μM R08 exp505]]|0.068||
|[[:results:exp525|Sulforaphane 9μM R08 exp525]]|0.068||
|[[:results:exp472|CI-1040 9.5μM R08 exp472]]|0.068||
|[[:results:exp274|Citral 50μM R06 exp274]]|0.065||
|[[:results:exp474|CR131-b 0.005μM R08 exp474]]|0.063||
|[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|0.061||
|[[:results:exp199|Etoposide 0.3μM R05 exp199]]|0.061||
|[[:results:exp451|Atovaquone 15μM R08 exp451]]|0.06||
|[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|0.059||
|[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|0.059||
|[[:results:exp459|Bleomycin 5μM R08 exp459]]|0.055||
|[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|0.054||
|[[:results:exp517|Quercetin 20μM R08 exp517]]|0.054||
|[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|0.054||
|[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|0.054||
|[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|0.054||
|[[:results:exp264|Arsenate 40μM R06 exp264]]|0.053||
|[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|0.053||
|[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|0.053||
|[[:results:exp439|QNZ 0.01μM R08 exp439]]|0.052||
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|0.052||
|[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|0.051||
|[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|0.072||
|[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|0.063||
{{:chemogenomics:comparison_plots:exp116_vs_exp211.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp134.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp135.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp485.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp440.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp456.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp488.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp535.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp234.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp512.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp435.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp3.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp294.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp489.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp85.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp443.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp526.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp450.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp520.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp80.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp492.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp503.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp505.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp525.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp472.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp274.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp474.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp355.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp199.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp451.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp441.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp357.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp459.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp498.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp517.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp363.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp21.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp478.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp264.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp354.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp374.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp439.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp529.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp524.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp2.png?nolink |}}
{{:chemogenomics:comparison_plots:exp116_vs_exp259.png?nolink |}}
No GO term hits below threshold. (FDR <0.05)
^GO Term^Fold Change^Genes^
|tetrahydrofolate interconversion|207.24|MTHFD2,SHMT2,MTHFD1L|
|tetrahydrofolate metabolic process|157.90|MTR,MTHFD2,SHMT2,MTHFD1L|
|folic acid metabolic process|157.90|MTHFD2,SLC25A32,SHMT2,SLC19A1|
|folic acid-containing compound metabolic process|132.63|MTR,MTRR,MTHFD2,SHMT2,MTHFD1L,SLC19A1|
|pteridine-containing compound metabolic process|124.79|MTR,MTRR,MTHFD2,SLC25A32,SHMT2,MTHFD1L,SLC19A1|
|purine ribonucleoside monophosphate biosynthetic process|122.81|ADK,NUDT2,ADSS2,IMPDH2|
|purine nucleoside monophosphate biosynthetic process|110.53|ADK,NUDT2,ADSS2,IMPDH2|
|AMP metabolic process|100.48|ADK,NUDT2,AK2,ADSS2|
|positive regulation of mitochondrial membrane permeability|78.95|BAK1,VDAC2,BCL2L11,TP53|
|positive regulation of membrane permeability|71.31|BAK1,VDAC2,BCL2L11,TP53|
|purine ribonucleoside monophosphate metabolic process|69.08|ADK,NUDT2,AK2,ADSS2,IMPDH2|
|water-soluble vitamin metabolic process|66.70|MTR,MMACHC,MTRR,MTHFD2,SLC25A32,SHMT2,SLC19A1|
|purine nucleoside monophosphate metabolic process|65.79|ADK,NUDT2,AK2,ADSS2,IMPDH2|
|ribonucleoside monophosphate biosynthetic process|65.02|ADK,NUDT2,ADSS2,IMPDH2|
|ribonucleoside monophosphate metabolic process|46.83|ADK,NUDT2,AK2,ADSS2,IMPDH2|
|dicarboxylic acid metabolic process|43.96|ADSS2,MTRR,MTHFD2,SLC25A32,SHMT2,MTHFD1L,SLC19A1|
|vitamin metabolic process|39.88|MTR,MMACHC,MTRR,MTHFD2,SLC25A32,SHMT2,SLC19A1|
|nucleoside monophosphate metabolic process|36.36|ADK,NUDT2,AK2,ADSS2,IMPDH2|
|cellular modified amino acid metabolic process|33.93|MTR,MTRR,MTHFD2,SLC25A32,SHMT2,MTHFD1L,SLC19A1|